Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Leuk Lymphoma. 2019 Nov 12;61(3):728–731. doi: 10.1080/10428194.2019.1689394

Table 1.

Patient characteristics for Agent Orange exposed and control subjects.

Sample # Gender Race Branch of military Age at diagnosis MDS subtype Prior chemo/RT
AO01 Male White Navy 61 MDS No
AO02 Male White Army Reserve 59 MDS-U No
AO03 Male White Army 67 RAEB-2 Yes
AO04 Male White Air Force 64 MDS-MLD Yes
AO05 Male White Army 65 RAEB-1 Yes
AO06 Male White Air Force 77 MDS-U No
AO07 Male White Air Force 61 MDS-MLD No
AO08 Male White Army 61 MDS-U No
AO09 Male White Army 62 MDS-U Unknown
AO10 Male White Army 66 MDS No
AO11 Male White Army 65 RARS No
AO12 Male White Army 73 MDS-U No
AO13 Male White Army 67 RAEB-2 Yes
AO14 Male White Army 76 RAEB-2 No
AO15 Male White Army 63 MDS-MLD No
AO16 Male White Army 59 MDS-U No
AO17 Male White Navy 64 MDS-U Unknown
AO18 Male White Army 67 RAEB-1 Yes
AO19 Male White Army 64 MDS-U No
AO20 Male White Army 68 MDS-U No
AO21 Male White Army 64 MDS-U No
AO22 Male White Army 73 MDS No
AO23 Male White Air Force 68 MDS-MLD No
AO24 Male White Air Force 65 MDS-U No
AO25 Male White Navy 61 RARS No
AO26 Male White Army 61 RARS No
AO27 Male White Army 71 RARS No
AO28 Male White Army 71 MDS-U Yes
AO29 Male White Navy 65 MDS-U No
AO30 (control) Female White N/A 92 RAEB-2 No
AO31 (control) Female Hispanic N/A 53 RARS No
AO32 (control) Female White N/A 48 RAEB-2 No
AO33 (control) Female White N/A 66 RCMD Yes
AO34 (control) Male White N/A 39 MDS-U No
AO35 (control) Male White N/A 73 RAEB-1 No
AO36 (control) Male White N/A 52 RAEB-1 No
AO37 (control) Male White N/A 57 RAEB-1 No
AO38 (control) Male White N/A 66 RAEB-2 No

RT: radiation therapy.